Blog

May 21, 2024, 12:00

Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center shared on X:

“A review in International Journal of Oncology discusses mechanisms of senescence‑associated drug resistance in lymphoma and highlights emerging strategies using senolytics, which are drugs designed to specifically target senescent cells.”

Read further.
Source: Michael Wang/X

cancer Cancer Treatment Strategies Cellular Therapy drug resistance mechanisms International Journal of Oncology lymphoma MD Anderson Cancer Center medical review Michael Wang Myeloma OncoDaily Oncology oncology research senescence-associated drug resistance senescent cells senolytics Stem Cell Transplantation

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage